The key themes that defined the year behind us will also shape the one ahead. The most-read articles of 2025 tracked a return ...

Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer. The company’s proprietary oncolytic ...

A fourth wave of the "GlassWorm" campaign is targeting macOS developers with malicious VSCode/OpenVSX extensions that deliver ...

Each month, hosts Keith Shaw and Matt Egan are joined by a top-tier panel of editors from Foundry’s global team to discuss hot technology topics and give insights from IT buyers in markets around the ...

Working It is the FT's workplace, future of work and leadership brand, led by Isabel Berwick. Sign up for Isabel's weekly Working It newsletter (here) which offers a sideways glance at the week's big ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.

Chart does not reflect overnight price.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip ...

Subscribe to our weekly newsletter for the latest in industry news, expert insights, dedicated information security content and online events.